Timing is everything: new study seeks best sequence for brain metastases treatment
NCT ID NCT07638709
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This observational study looks at adults with non-small cell lung cancer that has spread to the brain. Researchers want to see if getting radiation and immunotherapy 30 days apart or closer together changes how long the brain tumors stay stable and how long patients live. Participants continue their normal treatment and allow researchers to collect health data, blood samples, and MRI scans during regular checkups.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN METASTASASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Xiangya Hospital of Central South University
Changsha, Hunan, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Brain surgery gets a GPS: network maps may help remove tumors while preserving function
- Massive study tests yearly brain scans for lung cancer patients
- New combo attack on aggressive breast cancer brain tumors shows promise in early trial
- MRI-Guided radiation shows promise for brain tumors in new trial
- Real-World data reveals how lung cancer drug lorlatinib performs outside the lab
- New hope for advanced cancers? pfizer launches early trial of PF-08046033